F.D.A. Clears New Cancer-Fighting Drug From Roche

.

F.D.A. Clears New Cancer-Fighting Drug From Roche

A new drug from the drug company Roche has been given the nod by the US Food and Drug Administration (FDA) to improve the treatment of patients suffering from a kind of cancer of the blood and bone marrow.

Roche is calling the new medicine Gazyva which is meant to fight chronic lymphocytic leukemia along with added treatment with chemotherapy. It is meant for those patients who have never before been treated for the same.

Gazyva provides relief in this cancer by destroying cancer cells and enabling the natural immune system of the body to fight against them.

The FDA gave its approval to Gazyva after proof that the drug along with chemotherapy was a better treatment to chemotherapy alone in slowing the progress of the cancer cells.

It was also seen that cancer patients who got treatment from Gazyva combined with chemotherapy had a higher survival rate with 23 months before death, relapse or spreading of the cancer cells.

Earlier treatments treated only with chemotherapy only got 11.1 months.

The new drug Gazyva will be sold by Roche s Genentech unit.


Latest News

Mobileye to be the Largest Israeli IPO in the U.S.
GoPro Fails to Hold On to Its Blockbuster Start
Alpha Natural Resources Plan to Cut Down 1,100  Jobs in Coal Mines
California Proposes Very Humble Rate Hikes for Obamacare in 2015
Patients receiving 'second choice' drugs due to supply deficiencies
NuvaRing makers warn women of side effects
Australian couple refuses to take their surrogate baby with Down syndrome
Depression and anxiety happen in teens due to insomnia
Sierra Leone declares state of emergency with Ebola outbreak
Increase of Sales Tax on Cigarettes Lowered Smoking Rate in Japan by 20%
Republican House Votes accuse US President Barack Obama of Impeachment
In a Peppy Second Quarter US economy Experiences a 4% Growth